D. Venkatesan, Sheetal Kaur, Mahalaxmi Iyer, Mohan Gomathi, Reza Rastmanesh, B. Vellingiri
{"title":"微生物群和 COVID-19:健康与疾病的新型诊断方法","authors":"D. Venkatesan, Sheetal Kaur, Mahalaxmi Iyer, Mohan Gomathi, Reza Rastmanesh, B. Vellingiri","doi":"10.2174/0126667975291873240506111439","DOIUrl":null,"url":null,"abstract":"\n\nCoronavirus Disease 2019 (COVID-19) is a pandemic disease caused by a novel virus,\nSARS-CoV-2. COVID-19-infected people have high chance of altered microbiota in various regions\nof the human body, such as gut, oral, and respiratory pathways. In one such case, gastrointestinal\nsymptoms are mostly caused by disturbances in gut microbiota. The gut microbiota shows magnificent\nchanges in response to SARS-CoV-2 infection. The impairment of microbiota levels in humans\ncan lead to various neurological diseases. Here, in the present chapter, we have discussed the probable\nmechanistic approaches of SARS-CoV-2 infection altering microbiota present in the gut, oral,\nand respiratory regions, thereby leading to neurological diseases – Parkinson’s Disease (PD), Alzheimer’s\nDisease (AD) and depression mediated by inflammatory cytokines. We conclude that although\nthere are many underpinnings in the current knowledge on the mechanism of COVID-19-\nrelated microbiota disturbance, it can be speculated that these mechanistic approaches may be more\nthan just a coincidence. We advise conducting extensive epidemiologic investigations to create diagnostic\nand therapeutic options in the future.\n","PeriodicalId":10815,"journal":{"name":"Coronaviruses","volume":"7 13","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Microbiota and COVID-19: A Novel Diagnostic Approach to Health and Diseases\",\"authors\":\"D. Venkatesan, Sheetal Kaur, Mahalaxmi Iyer, Mohan Gomathi, Reza Rastmanesh, B. Vellingiri\",\"doi\":\"10.2174/0126667975291873240506111439\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nCoronavirus Disease 2019 (COVID-19) is a pandemic disease caused by a novel virus,\\nSARS-CoV-2. COVID-19-infected people have high chance of altered microbiota in various regions\\nof the human body, such as gut, oral, and respiratory pathways. In one such case, gastrointestinal\\nsymptoms are mostly caused by disturbances in gut microbiota. The gut microbiota shows magnificent\\nchanges in response to SARS-CoV-2 infection. The impairment of microbiota levels in humans\\ncan lead to various neurological diseases. Here, in the present chapter, we have discussed the probable\\nmechanistic approaches of SARS-CoV-2 infection altering microbiota present in the gut, oral,\\nand respiratory regions, thereby leading to neurological diseases – Parkinson’s Disease (PD), Alzheimer’s\\nDisease (AD) and depression mediated by inflammatory cytokines. We conclude that although\\nthere are many underpinnings in the current knowledge on the mechanism of COVID-19-\\nrelated microbiota disturbance, it can be speculated that these mechanistic approaches may be more\\nthan just a coincidence. We advise conducting extensive epidemiologic investigations to create diagnostic\\nand therapeutic options in the future.\\n\",\"PeriodicalId\":10815,\"journal\":{\"name\":\"Coronaviruses\",\"volume\":\"7 13\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Coronaviruses\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0126667975291873240506111439\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Coronaviruses","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0126667975291873240506111439","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Microbiota and COVID-19: A Novel Diagnostic Approach to Health and Diseases
Coronavirus Disease 2019 (COVID-19) is a pandemic disease caused by a novel virus,
SARS-CoV-2. COVID-19-infected people have high chance of altered microbiota in various regions
of the human body, such as gut, oral, and respiratory pathways. In one such case, gastrointestinal
symptoms are mostly caused by disturbances in gut microbiota. The gut microbiota shows magnificent
changes in response to SARS-CoV-2 infection. The impairment of microbiota levels in humans
can lead to various neurological diseases. Here, in the present chapter, we have discussed the probable
mechanistic approaches of SARS-CoV-2 infection altering microbiota present in the gut, oral,
and respiratory regions, thereby leading to neurological diseases – Parkinson’s Disease (PD), Alzheimer’s
Disease (AD) and depression mediated by inflammatory cytokines. We conclude that although
there are many underpinnings in the current knowledge on the mechanism of COVID-19-
related microbiota disturbance, it can be speculated that these mechanistic approaches may be more
than just a coincidence. We advise conducting extensive epidemiologic investigations to create diagnostic
and therapeutic options in the future.